A Phase II Study of Preoperative Dose-Dense Chemotherapy With Sequential Doxorubicin and Docetaxel for Initial Treatment of Operable and Inoperable Stage II-IIIB Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 25 Jan 2013
At a glance
- Drugs Docetaxel (Primary) ; Doxorubicin (Primary) ; Cyclophosphamide; Filgrastim; Fluorouracil; Methotrexate; Tamoxifen
- Indications Breast cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Jul 2011 Planned end date changed from 1 Nov 2015 to 1 Oct 2015 as reported by ClinicalTrials.gov.